Youth-onset type 2 diabetes consensus report: Current status, challenges, and priorities

Diabetes Care

Volumn 39, Issue 9, 2016, Pages 1635-1642

  Nadeau, Kristen J ^a,b   Anderson, Barbara J ^c   Berg, Erika G ^d   Chiang, Jane L ^d   Chou, Hubert ^e   Copeland, Kenneth C ^f   Hannon, Tamara S ^g   Huang, Terry T K ^h   Lynch, Jane L ⁱ   Powell, Jeff ^j   Sellers, Elizabeth ^k   Tamborlane, William V ^l   Zeitler, Philip ^a,b  

^a Children's Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d AMERICAN DIABETES ASSOCIATION   (United States)

^e Clinical Development   (United States)

^f UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^g INDIANA UNIVERSITY   (United States)

^h CITY UNIVERSITY OF NEW YORK   (United States)

ⁱ UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^j Northern Navajo Medical Center   (United States)

^k HEALTH SCIENCES CENTRE   (Canada)

^l YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; METFORMIN; ROSIGLITAZONE; TRIACYLGLYCEROL; ANTIDIABETIC AGENT;

ARTICLE; CARDIOVASCULAR PARAMETERS; COMMUNITY CARE; DISEASE DURATION; GLYCEMIC CONTROL; HEALTH CARE DELIVERY; HUMAN; INCIDENCE; INDIGENOUS PEOPLE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PUBERTY; RISK ASSESSMENT; RISK FACTOR; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; SOCIAL STATUS; TRANSLATIONAL RESEARCH; TREATMENT PLANNING; ADOLESCENT; ALLOSTASIS; CHILD; CONSENSUS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE MANAGEMENT; ETHNIC GROUP; KINESIOTHERAPY; METABOLISM; MINORITY GROUP; PSYCHOLOGY; RISK; RISK REDUCTION; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; AGE OF ONSET; ALLOSTASIS; CHILD; CONSENSUS; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE MANAGEMENT; ETHNIC GROUPS; EXERCISE THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; MINORITY GROUPS; RISK; RISK REDUCTION BEHAVIOR; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84986224381     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1066     Document Type: Article

References (69)

1. Zeitler P, Chou HS, Copeland KC, Geffner M. Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options. Curr Diab Rep 2015;15:28
2. Berends LM, Ozanne SE. Early determinants of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 2012;26:569-580
3. Lawrence JM, Imperatore G, Pettitt DJ, et al. Incidence of diabetes in United States youth by diabetes type, race/ethnicity, and age, 2008-2009 (Abstract). Diabetes 2014;63(Suppl. 1): A407
4. Dabelea D, Mayer-Davis EJ, Saydah S, et al.; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311:1778-1786
5. Fazeli Farsani S, van der Aa MP, van der Vorst MMJ, Knibbe CA, de Boer A. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: A systematic review and evaluation of methodological approaches. Diabetologia 2013;56:1471-1488
6. Petitti DB, Klingensmith GJ, Bell RA, et al.; SEARCH for Diabetes in Youth Study Group. Glycemic control in youth with diabetes: The SEARCH for Diabetes in Youth Study. J Pediatr 2009;155:668-672.e1-e3
7. Hamman RF, Bell RA, Dabelea D, et al.; SEARCH for Diabetes in Youth Study Group. The SEARCH for Diabetes in Youth study: Rationale, findings, and future directions. Diabetes Care 2014;37:3336-3344
8. Fu J, Prasad HC. Changing epidemiology of metabolic syndrome and type 2 diabetes in Chinese youth. Curr Diab Rep 2014;14:447
9. Prasad AN. Type 2 diabetes mellitus in young need for early screening. Indian Pediatr 2011; 48:683-688
10. Kelsey MM, Geffner ME, Guandalini C, et al.; Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) Study Group. Presentation and effectiveness of early treatment of type 2 diabetes in youth: Lessons from the TODAY study. Pediatr Diabetes 2016;17: 212-221
11. Zeitler P, Hirst K, Pyle L, et al.; TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012;366:2247-2256
12. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and b-cell function in TODAY. Diabetes Care 2013;36:1749-1757
13. Zeitler P, Hirst K, Copeland KC, et al.; TODAY Study Group. HbA1c after a short period of monotherapy with metformin identifies durable glycemic control among adolescents with type 2 diabetes. Diabetes Care 2015;38:2285-2292
14. Rascati K, Richards K, Lopez D, Cheng L-I, Wilson J. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Diabetes Obes Metab 2013;15:901-905
15. Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058
16. Kahn SE, Lachin JM, Zinman B, et al.; ADOPT Study Group. Effects of rosiglitazone, glyburide, and metformin on b-cell function and insulin sensitivity in ADOPT. Diabetes 2011;60:1552-1560
17. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006;60:759-763
18. Copeland KC, Zeitler P, Geffner M, et al.; TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab 2011;96:159-167
19. Klingensmith GJ, Connor CG, Ruedy KJ, et al.; Pediatric Diabetes Consortium. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatr Diabetes 2016;17:266-273
20. Sellers EAC, Yung G, Dean HJ. Dyslipidemia and other cardiovascular risk factors in a Canadian First Nation pediatric population with type 2 diabetes mellitus. Pediatr Diabetes 2007; 8:384-390
21. Hannon TS, Arslanian SA. The changing face of diabetes in youth: Lessons learned from studies of type 2 diabetes. Ann N Y Acad Sci 2015; 1353:113-137
22. Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2014;37:436-443
23. Klingensmith GJ, Pyle L, Nadeau KJ, et al.; TODAY Study Group. Pregnancy outcomes in youth with type 2 diabetes: The TODAY study experience. Diabetes Care 2016;39:122-129
24. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: A study of discordant sibships. Diabetes 2000;49:2208-2211
25. Mendelson M, Cloutier J, Spence L, Sellers E, Taback S, Dean H. Obesity and type 2 diabetes mellitus in a birth cohort of First Nation children born to mothers with pediatric-onset type 2 diabetes. Pediatr Diabetes 2011;12:219-228
26. World Health Organization. Social Determinants of Health. The Solid Facts. 2nd edition. Wilkinson R,MarmotM, Eds. [Internet]. Available from http://www.euro.who.int/en/publications/ abstracts/social-determinants-of-health.-thesolid- facts. Accessed 21 December 2015
27. Egerter S, Braveman P, Sadegh-Nobari T, Grossman-Kahn R, Dekker M. Robert Wood Johnson Foundation Commission to Build a Healthier America. Exploring the Social Determinants of Health. Education and Health, Issue Brief 5 [Internet], 2011. http://www.rwjf.org/ en/library/research/2011/05/education-mattersfor- health.html. Accessed 21 December 2015
28. Gracey M, King M. Indigenous health part 1: Determinants and disease patterns. Lancet 2009;374:65-75
29. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med 1993;153:2093-2101
30. Braveman P, Gottlieb L. The social determinants of health: It's time to consider the causes of the causes. Public Health Rep 2014;129 Suppl. 2:19-31
31. Duncan AE, Auslander WF, Bucholz KK, Hudson DL, Stein RI, White NH. Relationship between abuse and neglect in childhood and diabetes in adulthood: Differential effects by sex, national longitudinal study of adolescent health. Prev Chronic Dis 2015;12:E70
32. Garg A, Jack B, Zuckerman B. Addressing the social determinants of health within the patient-centered medical home: Lessons from pediatrics. JAMA 2013;309:2001-2002
33. Glazier RH, Bajcar J, Kennie NR, Willson K. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 2006;29:1675-1688
34. Brackney DE, Cutshall M. Prevention of type 2 diabetes among youth: A systematic review, implications for the school nurse. J Sch Nurs 2015;31:6-21
35. Ho M, Garnett SP, Baur LA, et al. Impact of dietary and exercise interventions on weight change and metabolic outcomes in obese children and adolescents: A systematic review and meta-analysis of randomized trials. JAMA Pediatr 2013;167:759-768
36. McGavock J, Dart A, Wicklow B. Lifestyle therapy for the treatment of youth with type 2 diabetes. Curr Diab Rep 2015;15:568
37. Savoye M, Nowicka P, Shaw M, et al. Longterm results of an obesity program in an ethnically diverse pediatric population. Pediatrics 2011;127:402-410
38. Savoye M, Caprio S, Dziura J, et al. Reversal of early abnormalities in glucose metabolism in obese youth: Results of an intensive lifestyle randomized controlled trial. Diabetes Care 2014;37:317-324
39. Protudjer JLP, Dumontet J, McGavock JM. My voice: A grounded theory analysis of the lived experience of type 2 diabetes in adolescence. Can J Diabetes 2014;38:229-236
40. Hood KK, Beavers DP, Yi-Frazier J, et al. Psychosocial burden and glycemic control during the first 6 years of diabetes: Results from the SEARCH for Diabetes in Youth study. J Adolesc Health 2014;55:498-504
41. Anderson BJ, Edelstein S, Abramson NW, et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: Baseline data from the TODAY study. Diabetes Care 2011;34:2205-2207
42. Frerichs L, Brittin J, Robbins R, et al. SaludABLEOmaha: Improving readiness to address obesity through healthy lifestyle in a Midwestern Latino community, 2011 2013. Prev Chronic Dis 2015;12:E20
43. Huang TT, Drewnosksi A, Kumanyika S, Glass TA. A systems-oriented multilevel framework for addressing obesity in the 21st century. Prev Chronic Dis 2009;6:A82
44. Benavides S, Caballero J. Ashtanga yoga for children and adolescents for weight management and psychological well being: An uncontrolled open pilot study. Complement Ther Clin Pract 2009;15:110-114
45. Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch- GavanM, et al. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Horm Res 2009;72:287-301
46. Weigensberg MJ, Lane CJ, Avila Q, et al. Imagine HEALTH: Results from a randomized pilot lifestyle intervention for obese Latino adolescents using Interactive Guided ImagerySM. BMC Complement Altern Med 2014;14:28
47. Edwards RW, Jumper-Thurman P, Plested BA, Oetting ER, Swanson L. Community readiness: Research to practice. J Community Psychol 2000;28:291-307
48. Committee on Accelerating Progress in Obesity Prevention, Institute of Medicine. Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation. 1st ed. Washington, D.C., National Academies Press, 2012, 478 pp
49. The Oxford Handbook of the Social Science of Obesity. 1st ed. Oxford, U.K., Oxford University Press, 2011
50. Shaibi GQ, Konopken Y, Hoppin E, Keller CS, Ortega R, Castro FG. Effects of a culturally grounded community-based diabetes prevention program for obese Latino adolescents. Diabetes Educ 2012;38:504-512
51. Collective Impact Forum [Internet]. Available from https://collectiveimpactforum.org. Accessed 21 October 2015
52. Bacha F, Pyle L, Nadeau K, et al.; TODAY Study Group. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes 2012;13: 376-383
53. Mencin AA, Loomba R, Lavine JE. Caring for children with NAFLD and navigating their care into adulthood. Nat Rev Gastroenterol Hepatol 2015;12:617-628
54. Bjornstad P, Maahs DM, Cherney DZ, et al. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes. Diabetes Care 2014;37:3033-3039
55. Nadeau KJ, Zeitler PS, Bauer TA, et al. Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity. J Clin Endocrinol Metab 2009;94:3687-3695
56. Matthews KA, Pantesco EJ. Sleep characteristics and cardiovascular risk in children and adolescents: An enumerative review. Sleep Med 2016;18:36-49
57. ClinicalTrials.gov [Internet]. Available from https://clinicaltrials.gov. Accessed 6 January 2016
58. U.S. Food and Drug Administration [Internet]. Available from http://www.fda.gov. Accessed 6 January 2016
59. Tamborlane WV, Klingensmith G. Crisis in care: Limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care 2013;36:1777-1778
60. Karres J, Pratt V, Guettier J-M, et al. Joining forces: A call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes. Diabetes Care 2014;37:2665-2667
61. Karres J, Tomasi P. New medicines for type 2 diabetes in adolescents: Many products, few patients. Expert Rev Clin Pharmacol 2013; 6:227-229
62. Crume TL, Hamman RF, Isom SP, et al. Factors influencing time to case ascertainment in youth with type 1 (T1D) and type 2 diabetes (T2D) in the SEARCH for Diabetes in Youth study (Abstract). Diabetes 2013;62(Suppl. 1):A412
63. Nambam B, Silverstein J, Cheng P, et al.; Pediatric Diabetes Consortium. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: Enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 11 March 2016 [Epub ahead of print]. DOI: 10.1111/ pedi.12377
64. Tamborlane WV, Haymond MW, Dunger D, et al.; NICHD DiabetesWorking Group. Expanding treatment options for youth with type 2 diabetes: Current problems and proposed solutions: A white paper from the NICHD Diabetes Working Group. Diabetes Care 2016;39:323-329
65. Anderson BJ, McKay SV. Barriers to glycemic control in youth with type 1 diabetes and type 2 diabetes. Pediatr Diabetes 2011;12:197-205
66. Song SH. Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population. BMJ Open Diabetes Res Care 2015;3:e000044
67. Kahn SE, Haffner SM, Heise MA, et al.; ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-2443
68. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC; UK Prospective Diabetes Study (UKPDS) Group. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. Diabet Med 1998;15: 297-303
69. Imperatore G, Boyle JP, Thompson TJ, et al.; SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: Dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012; 35:2515-2520